In the case of the MPS group, compared with the control group, the expression of SPBC1773.02c, GPX1, and SOD2 was upregulated, while the expression of APX6, DHAR3, and CATB was downregulated. The gene discussed is GPX1; the disease is mucopolysaccharidosis.